全文获取类型
收费全文 | 975篇 |
免费 | 88篇 |
国内免费 | 61篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 67篇 |
妇产科学 | 10篇 |
基础医学 | 146篇 |
口腔科学 | 25篇 |
临床医学 | 196篇 |
内科学 | 255篇 |
皮肤病学 | 15篇 |
神经病学 | 17篇 |
特种医学 | 95篇 |
外科学 | 45篇 |
综合类 | 21篇 |
一般理论 | 2篇 |
预防医学 | 65篇 |
眼科学 | 4篇 |
药学 | 78篇 |
中国医学 | 2篇 |
肿瘤学 | 78篇 |
出版年
2023年 | 2篇 |
2021年 | 9篇 |
2020年 | 3篇 |
2019年 | 13篇 |
2018年 | 19篇 |
2017年 | 8篇 |
2016年 | 15篇 |
2015年 | 18篇 |
2014年 | 29篇 |
2013年 | 37篇 |
2012年 | 31篇 |
2011年 | 36篇 |
2010年 | 35篇 |
2009年 | 48篇 |
2008年 | 49篇 |
2007年 | 71篇 |
2006年 | 45篇 |
2005年 | 41篇 |
2004年 | 35篇 |
2003年 | 30篇 |
2002年 | 26篇 |
2001年 | 24篇 |
2000年 | 33篇 |
1999年 | 28篇 |
1998年 | 37篇 |
1997年 | 44篇 |
1996年 | 29篇 |
1995年 | 26篇 |
1994年 | 32篇 |
1993年 | 22篇 |
1992年 | 18篇 |
1991年 | 16篇 |
1990年 | 8篇 |
1989年 | 27篇 |
1988年 | 20篇 |
1987年 | 18篇 |
1986年 | 9篇 |
1985年 | 18篇 |
1984年 | 9篇 |
1983年 | 10篇 |
1982年 | 16篇 |
1981年 | 14篇 |
1980年 | 11篇 |
1979年 | 5篇 |
1978年 | 10篇 |
1977年 | 9篇 |
1976年 | 10篇 |
1975年 | 7篇 |
1973年 | 2篇 |
1972年 | 3篇 |
排序方式: 共有1124条查询结果,搜索用时 15 毫秒
41.
F. Despang A. Bernhardt A. Lode Th. Hanke D. Handtrack B. Kieback M. Gelinsky 《Acta biomaterialia》2010,6(3):1006-1013
A novel titanium-based material, containing no toxic or expensive alloying elements, was compared to the established biomaterials: commercially pure titanium (c.p. Ti) and Ti6Al4V. This material (Ti/1.3HMDS) featured similar hardness, yield strength and better wear resistance than Ti6Al4V, as well as better electrochemical properties at physiological pH 7.4 than c.p. Ti grade 1 of our study. These excellent properties were obtained by utilizing an alternative mechanism to produce a microstructure of very fine titanium silicides and carbides (<100 nm) embedded in an ultra-fine-grained Ti matrix (365 nm). The grain refinement was achieved by high-energy ball milling of Ti powder with 1.3 wt.% of hexamethyldisilane (HMDS). The powder was consolidated by spark plasma sintering at moderate temperatures of 700 °C. The microstructure was investigated by optical and scanning electron microscopy (SEM) and correlated to the mechanical properties. Fluorescence microscopy revealed good adhesion of human mesenchymal stem cells on Ti/1.3HMDS comparable to that on c.p. Ti or Ti6Al4V. Biochemical analysis of lactate dehydrogenase and specific alkaline phosphatase activities of osteogenically induced hMSC exhibited equal proliferation and differentiation rates in all three cases. Thus the new material Ti/1.3HMDS represents a promising alternative to the comparatively weak c.p. Ti and toxic elements containing Ti6Al4V. 相似文献
42.
43.
Background
Physical activity has been associated with a decreased risk for breast cancer. The biological mechanismn(s) underlying the association between physical activity and breast cancer is not clear. Most prominent hypothesis is that physical activity may protect against breast cancer through reduced lifetime exposure to endogenous hormones either direct, or indirect by preventing overweight and abdominal adiposity. In order to get more insight in the causal pathway between physical activity and breast cancer risk, we designed the Sex Hormones and Physical Exercise (SHAPE) study. Purpose of SHAPE study is to examine the effects of a 1-year moderate-to-vigorous intensity exercise programme on endogenous hormone levels associated with breast cancer among sedentary postmenopausal women and whether the amount of total body fat or abdominal fat mediates the effects. 相似文献44.
Balicki D Reisfeld RA Pertl U Beutler E Lode HN 《Proceedings of the National Academy of Sciences of the United States of America》2000,97(21):11500-11504
A major goal of cancer immunotherapy is the induction of a cell-mediated antitumor response in poorly immunogenic malignancies. We tested the hypothesis that this can be achieved by cytokine gene therapy with a novel histone H2A-based transient transfection procedure. This was tested by using cytokine genes encoding for IL-2 and a single chain IL-12 (scIL-12) fusion protein in a recently developed murine neuroblastoma model. Here, we demonstrate that cytokine gene transfer of IL-2 and scIL-12 with histone H2A results in the induction of an antitumor immune response that is superior in some respects to gene transfer with Superfect, a commercially available activated dendrimer commonly used to effect transfection with plasmids. Three lines of evidence support this contention. First, histone H2A-mediated transfection of IL-2 induces a natural killer cell-induced rejection of primary tumors in contrast to Superfect, which produces only a partial reduction in primary tumor growth. Second, the induction of a T cell-mediated protective tumor immunity following gene transfer of scIL-12 is more efficient with the histone H2A-mediated gene transfer because rejection of a lethal wild-type tumor cell challenge is accompanied by the greatest degree of MHC class I-restricted tumor cell killing in vitro. Third, histone H2A-mediated scIL-12 gene therapy induces the greatest release of mIFN-gamma from splenocytes of vaccinated animals in contrast to Superfect and other controls. 相似文献
45.
46.
47.
Hydrolytically activated etoposide prodrugs inhibit MDR-1 function and eradicate established MDR-1 multidrug-resistant T-cell leukemia 总被引:2,自引:0,他引:2
Schroeder U Bernt KM Lange B Wenkel J Jikai J Shabat D Amir R Huebener N Niethammer AG Hagemeier C Wiebusch L Gaedicke G Wrasidlo W Reisfeld RA Lode HN 《Blood》2003,102(1):246-253
Effective therapy of high-risk leukemia with established cytotoxic drugs may be limited by poor antitumor efficacy, systemic toxicity, and the induction of drug resistance. Here, we provide the first evidence that hydrolytically activated prodrugs may overcome these problems. For this purpose, VP16 was functionally blocked by hydrolytically cleavable carbonate linkers with unique characteristics to generate 2 novel prodrugs of VP16. First, we established a more than 3-log higher efficacy of the 2 prodrugs compared with VP16 on a panel of naturally drug-resistant tumor cell lines. Second, the prodrugs did overcome VP16-induced multidrug resistance-1 gene (MDR-1)-mediated multidrug resistance in vitro in a newly established VP16-resistant T-cell leukemia cell line MOVP-3 by functionally blocking MDR-1-mediated efflux. Third, in vivo studies showed a maximum tolerated dose of ProVP16-II (> 45mg/kg), which was at least 3-fold higher than that of VP16 (15 mg/kg). Finally, tests of ProVP16-II in a multidrug-resistant xenograft model of T-cell leukemia expressing MDR-1 indicated that only the mice treated with this prodrug revealed a complete and long-lasting regression of established, drug-resistant leukemia. In summary, the hydrolytically activated etoposide prodrugs proved effective against multidrug-resistant T-cell leukemia in vitro and in vivo and provide proof of concept for a highly promising new strategy for the treatment of MDR-1 drug-resistant malignancies. 相似文献
48.
49.
50.
Phorbol ester-sensitive EL4 murine thymoma cells respond to phorbol 12-
myristate 13-acetate with activation of ERK mitogen-activated protein
kinases, synthesis of interleukin-2, and death, whereas phorbol ester-
resistant variants of this cell line do not exhibit these responses.
Additional aspects of the resistant phenotype were examined, using a
newly-established resistant cell line. Phorbol ester induced morphological
changes, ERK activation, calcium-dependent activation of the c-Jun
N-terminal kinase (JNK), interleukin-2 synthesis, and growth inhibition in
sensitive but not resistant cells. A series of protein kinase C activators
caused membrane translocation of protein kinase C's (PKCs) alpha, eta, and
theta in both cell lines. While PKC eta was expressed at higher levels in
sensitive than in resistant cells, overexpression of PKC eta did not
restore phorbol ester-induced ERK activation to resistant cells. In
sensitive cells, PKC activators had similar effects on cell viability and
ERK activation, but differed in their abilities to induce JNK activation
and interleukin-2 synthesis. PD 098059, an inhibitor of the mitogen
activated protein (MAP)/ERK kinase kinase MEK, partially inhibited ERK
activation and completely blocked phorbol ester-induced cell death in
sensitive cells. Thus MEK and/or ERK activation, but not JNK activation or
interleukin-2 synthesis, appears to be required for phorbol ester-induced
toxicity. Alterations in phorbol ester response pathways, rather than
altered expression of PKC isoforms, appear to confer phorbol ester
resistance to EL4 cells.
相似文献